HomeGreater Than Icon
Procter & Gamble Health LtdGreater Than Icon
Procter & Gamble Health Ltd Financials
Company Logo

Procter & Gamble Health Ltd Financial Statement

Procter & Gamble Health Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue286.01
Operating Expense255.82
Net Profit16.78
Net Profit Margin5.87
Earning Per Share9.50
EBIDTA36.93
Effective Tax Rate42.37

Procter & Gamble Health Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Jun 2023
Total Revenue Annual1,229.62
Operating Expenses Annual904.94
Operating Profit Annual343.07
Interest Annual0.77
Depreciation28.10
Net Profit Annual229.47
Tax Annual84.73

Procter & Gamble Health Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Jun 2023
Cash Flow at the Beginning319.40
Cash Flow from Operations236
Cash Flow from Investing-21.50
Cash Flow from Financing-98.48
Cash Flow at the End435.42

Procter & Gamble Health Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Jun 2023
PBDIT Margin (%)27.90
PBIT Margin (%)25.62
PBT Margin (%)-7.65
Net PROFIT Margin (%)18.66
Return On Networth / Equity (%)33.56
Return On Networth /Employed (%)43.16
Return On Assets (%)31.54
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)1.69

Procter & Gamble Health Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Jun 2023
Fixed Assets Annual141.72
Total Current Assets Annual796.10
Non Current Assets Annual305.09
Total Shareholders Funds Annual750.89
Total Assets Annual1,101.19

Procter & Gamble Health Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 12, 2024, Procter & Gamble Health Ltd has a market capitalization of 8,382.75 Cr. Value Research classifies it as a Mid-Cap company.
Yes, Procter & Gamble Health Ltd is debt-free with a debt-to-equity ratio of 0.02.
In FY 2023 , Procter & Gamble Health Ltd recorded a total revenue of approximately 1,151.26 Cr marking a significant milestone in the company's financial performance.
Procter & Gamble Health Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.0% annually, respectively..
Procter & Gamble Health Ltd's current PE ratio is 41.71.
Procter & Gamble Health Ltd's ROCE averaged 44.1% from the FY ending March 2022 to 2024, with a median of 41.3%. It peaked at 50.0% in March 2024, reflecting strong capital efficiency over the period..
Procter & Gamble Health Ltd's latest EBIT is Rs. 274.04 Cr, surpassing the average EBIT of Rs. 280.93 Cr over the 5 years..